Related Experiment Video
Updated: Jun 12, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Invasive aspergillosis caused by cryptic species in transplant recipients: A review
Muneyoshi Kimura1,2, Shahid Husain1
1Transplant Infectious Diseases, Ajmera Transplant Program, University Health Network, Toronto, Ontario, M5G 2N2, Canada.
Abstract:
The clinical and microbiological characteristics of invasive aspergillosis (IA) caused by cryptic Aspergillus species have not been well-defined in transplant settings. However, IA is among the most common mould infections in solid organ and hematopoietic stem cell transplant recipients. Among 55 causative isolates in the 53 reported cases, Aspergillus calidoustus, A. lentulus, A. tubingensis, and A. udagawae were the four most common causative cryptic Aspergillus species. Newer diagnostic modalities, such as matrix-assisted laser desorption ionization-time of flight mass spectrometry, may help diagnose these cryptic species. Of the 24 cases with detailed clinical information, 13 had antifungal breakthrough infections. The 12-week mortality rates of all 24 cases, 7 cases of A. calidoustus, and 7 cases of A. lentulus were 46%, 43%, and 43%, respectively. Based on antifungal susceptibility profiles obtained from previous studies, an empiric antifungal regimen such as liposomal amphotericin B with or without echinocandin is recommended for A. calidoustus. A combination of an anti-mould azole and liposomal amphotericin B with or without an echinocandin is suggested for A. lentulus and A. udagawae. Additionally, any one of voriconazole, isavuconazole, or posaconazole with or without liposomal amphotericin B with or without an echinocandin is indicated for A. tubingensis. Newer antifungal agents may have more significant activity against Aspergillus cryptic species.
Insights
Invasive aspergillosis (IA) from cryptic Aspergillus species is a serious threat to transplant recipients. Newer diagnostics and antifungal strategies are crucial for managing these challenging infections.
Area of Science:
- Mycology
- Infectious Diseases
- Transplant Medicine
Background:
- Invasive aspergillosis (IA) is a common fungal infection in solid organ and hematopoietic stem cell transplant recipients.
- The clinical and microbiological features of IA caused by cryptic Aspergillus species remain poorly understood in these immunocompromised populations.
Purpose of the Study:
- To define the clinical and microbiological characteristics of IA caused by cryptic Aspergillus species in transplant recipients.
- To review diagnostic approaches and antifungal susceptibility patterns for guiding treatment strategies.
Main Methods:
- Retrospective analysis of reported cases of IA caused by cryptic Aspergillus species.
- Review of diagnostic modalities including matrix-assisted laser desorption ionization-time of flight mass spectrometry.
- Analysis of antifungal susceptibility data and treatment outcomes.
Main Results:
- Aspergillus calidoustus, A. lentulus, A. tubingensis, and A. udagawae were the most common cryptic species identified.
- Antifungal breakthrough infections occurred in 13 of 24 cases with detailed information.
- 12-week mortality rates were high, around 43-46% for specific species and overall.
Conclusions:
- Cryptic Aspergillus species pose a significant challenge in transplant recipients, often presenting with high mortality.
- Advanced diagnostics like MALDI-TOF MS are vital for accurate species identification.
- Tailored antifungal regimens, potentially including newer agents, are recommended based on susceptibility profiles.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Fungal Phylum Ascomycota
Cryptococcal Meningitis

